Stay updated on Seagen Press Releases
Sign up to get notified when there's something new on the Seagen Press Releases page.
Latest updates to the Seagen Press Releases page
- ChecktodayChange DetectedPfizer has recently elected Tim Buckley to its Board of Directors and received FDA approval for its new hemophilia treatment, while notable updates on their COVID-19 vaccine initiatives have been removed.SummaryDifference35%
- Check8 days agoChange DetectedPfizer has declared its fourth-quarter 2024 dividend and will showcase scientific advancements at IDWeek 2024, while notable announcements regarding RSV vaccine results and second-quarter financial performance have been removed.SummaryDifference16%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedPfizer has voluntarily withdrawn all lots of its sickle cell disease treatment OXBRYTA® from worldwide markets, while also receiving a positive CHMP opinion for its Omicron-adapted COVID-19 vaccine in the EU.SummaryDifference25%
- Check164 days agoChange DetectedThe value on the webpage has changed from Pfizer Announces Positive Overall Survival in Phase 3 Trial of ADCETRIS┬« Regimen in Patients with Relapsed/ÔÇïRefractory Diffuse Large B-cell Lymphoma (DLBCL) to Pfizer Announces New Chief Strategy and Innovation Officer. This represents a shift in focus from a clinical trial announcement to a leadership appointment within Pfizer.SummaryDifference17%
- Check169 days agoChange DetectedThe value on the webpage has changed from '03.05.2024 Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference' to 'May 2024 05.01.2024 Pfizer Reports First-Quarter 2024 Results.' This change likely represents an update in the announcement or news related to Pfizer's activities or financial results.SummaryDifference12%
- Check171 days agoChange DetectedThe value February 2024 02.29.2024 Pfizer Oncology Hosts Innovation Day, Highlighting Fully Integrated Organization, Robust Portfolio, and Strategic Priorities to Drive Long-Term Sustainable Growth 02.29.2024 Pfizer Announces Positive Top-Line Data for Full Season Two Efficacy of ABRYSVO® for RSV in Older Adults has recently changed to 04.29.2024 FDA Grants Full Approval for TIVDAK® to Treat Recurrent or Metastatic Cervical Cancer 04.29.2024 Pfizer Highlights Progress in Accelerating Breakthrough Cancer Medicines at ASCO 2024 Annual Meeting represents the latest updates and announcements in the field of oncology and cancer treatment by Pfizer.SummaryDifference34%
Stay in the know with updates to Seagen Press Releases
Enter your email address, and we'll notify you when there's something new on the Seagen Press Releases page.